Novo Nordisk’s (NVO) Wegovy Pill Crushes Eli Lilly’s (LLY) Foundayo In Early Prescription Race

Novo Nordisk’s oral Wegovy pill has surpassed three million prescriptions in just over five months, cementing its place among the strongest U.S. pharmaceutical launches by volume on record. The three million prescription milestone translates to roughly one prescription filled every five seconds, reflecting relentless consumer demand since the drug became available in January 2026. Wegovy…

Read More

Investors Flee Tech Stocks And Rotate Into Defensive Sectors As Rate Fears Return

Wall Street’s longest winning streak in three years came to an abrupt end as investors abandoned high-flying technology shares in dramatic fashion. A stronger-than-expected May jobs report reignited fears that U.S. interest rates could rise again before the end of the year, rattling equity markets broadly. The Nasdaq composite suffered its worst single-day decline in…

Read More
erin perrine weight loss

Next-Generation Weight-Loss Drugs Aim To Outperform Zepbound (LLY) And Wegovy (NVO) On Side Effects And Results

A new wave of experimental weight-loss drugs is drawing serious attention from researchers and patients frustrated with the limitations of current GLP-1 medications. Drugs like Zepbound and Wegovy have transformed obesity treatment, but persistent side effects such as severe nausea and vomiting remain a significant barrier for many patients. Scientists are now developing alternatives that…

Read More